紫金桃科紫金桃属植物:民族植物学、药用特性和植物化学研究进展

I. Cock, M. Cheesman
{"title":"紫金桃科紫金桃属植物:民族植物学、药用特性和植物化学研究进展","authors":"I. Cock, M. Cheesman","doi":"10.1201/B22426-20","DOIUrl":null,"url":null,"abstract":"Plants have been used as therapeutic agents since the start of civilization. In many developing countries, herbal medicinal systems remain important in the treatment of many ailments. Ayuvedic medicine is still commonly practiced within India with an estimated 85% of Indians still using crude plant preparations for the treatment of wide variety of diseases and ailments [79]. Traditional Chinese medicine (TCM) and African medicinal systems also account for major portion of healthcare in their populations. Even in countries where allopathic/Western medicine is dominant, medicinal plants still make significant contributions. Furthermore, many people are returning to herbal medicine systems due to the perception that natural medicines are often a safer alternative than allopathic drugs. Individuals are also seeking treatments for diseases, which have not yet been remedied by modern medicine. \nMany of the prescription drugs currently marketed for a wide variety of ailments were originally isolated from plants and/or are semi-synthetic analogues of phytochemicals. It has been estimated that approximately 25% of all prescription drugs currently in use are of plant origin [122, 194]. Furthermore, 75% of new anticancer drugs marketed between 1981 and 2006 were derived from plant compounds [122]. Traditional plant-based medicines are generally used as crude formulations (e.g., infusions, tinctures and extracts, essential oils, powders, poultices, and other herbal preparations). Modern natural product drug discovery generally focuses on isolating and characterizing the individual phytochemical components with the aim of producing an analogue with increased bioactivity/bioavailability. Such studies have given rise to many useful drugs such as quinine (from Cinchona spp.), digoxin (from Digitalis spp.) as well as the anticancer drug paclitaxel (from Taxus brevifolia Nutt.) and vincristine and vinblastine (from Vinca rosea). However, the bioactivities observed for crude extracts are often much enhanced or even entirely different to those seen for the individual components [32, 81]. Crude plant extracts may contain hundreds, or even thousands, of different chemical constituents that interact in complex ways. Often it is not known how an extract works, even when its therapeutic benefit is well established. Thus, phytochemical and mechanistic studies of traditional medicines may be complex, and it is often difficult to assign single compound/bioactivity relationship.","PeriodicalId":187080,"journal":{"name":"Bioactive Compounds of Medicinal Plants","volume":"143 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"33","resultStr":"{\"title\":\"Plants of the Genus Syzygium (Myrtaceae): A Review on Ethnobotany, Medicinal Properties, and Phytochemistry\",\"authors\":\"I. Cock, M. Cheesman\",\"doi\":\"10.1201/B22426-20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Plants have been used as therapeutic agents since the start of civilization. In many developing countries, herbal medicinal systems remain important in the treatment of many ailments. Ayuvedic medicine is still commonly practiced within India with an estimated 85% of Indians still using crude plant preparations for the treatment of wide variety of diseases and ailments [79]. Traditional Chinese medicine (TCM) and African medicinal systems also account for major portion of healthcare in their populations. Even in countries where allopathic/Western medicine is dominant, medicinal plants still make significant contributions. Furthermore, many people are returning to herbal medicine systems due to the perception that natural medicines are often a safer alternative than allopathic drugs. Individuals are also seeking treatments for diseases, which have not yet been remedied by modern medicine. \\nMany of the prescription drugs currently marketed for a wide variety of ailments were originally isolated from plants and/or are semi-synthetic analogues of phytochemicals. It has been estimated that approximately 25% of all prescription drugs currently in use are of plant origin [122, 194]. Furthermore, 75% of new anticancer drugs marketed between 1981 and 2006 were derived from plant compounds [122]. Traditional plant-based medicines are generally used as crude formulations (e.g., infusions, tinctures and extracts, essential oils, powders, poultices, and other herbal preparations). Modern natural product drug discovery generally focuses on isolating and characterizing the individual phytochemical components with the aim of producing an analogue with increased bioactivity/bioavailability. Such studies have given rise to many useful drugs such as quinine (from Cinchona spp.), digoxin (from Digitalis spp.) as well as the anticancer drug paclitaxel (from Taxus brevifolia Nutt.) and vincristine and vinblastine (from Vinca rosea). However, the bioactivities observed for crude extracts are often much enhanced or even entirely different to those seen for the individual components [32, 81]. Crude plant extracts may contain hundreds, or even thousands, of different chemical constituents that interact in complex ways. Often it is not known how an extract works, even when its therapeutic benefit is well established. Thus, phytochemical and mechanistic studies of traditional medicines may be complex, and it is often difficult to assign single compound/bioactivity relationship.\",\"PeriodicalId\":187080,\"journal\":{\"name\":\"Bioactive Compounds of Medicinal Plants\",\"volume\":\"143 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"33\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioactive Compounds of Medicinal Plants\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1201/B22426-20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioactive Compounds of Medicinal Plants","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1201/B22426-20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 33

摘要

自从人类文明开始以来,植物就被用作治疗剂。在许多发展中国家,草药系统在治疗许多疾病方面仍然很重要。阿育吠陀医学在印度仍然很普遍,估计85%的印度人仍然使用粗植物制剂来治疗各种疾病[79]。传统中医和非洲医疗系统也占其人口医疗保健的主要部分。即使在对抗疗法/西药占主导地位的国家,药用植物仍然做出了重大贡献。此外,许多人正在回归草药系统,因为他们认为天然药物往往比对抗药物更安全。有些人还在寻求现代医学尚未治愈的疾病的治疗方法。目前市场上许多治疗各种疾病的处方药最初都是从植物中分离出来的,或者是植物化学物质的半合成类似物。据估计,目前使用的所有处方药中约有25%来自植物[122,194]。此外,1981年至2006年间,75%的新型抗癌药物来自植物化合物[122]。传统的植物性药物通常作为粗制剂使用(例如,输液、酊剂和提取物、精油、粉末、药膏和其他草药制剂)。现代天然产物药物的发现通常侧重于分离和表征单个植物化学成分,目的是生产具有更高生物活性/生物利用度的类似物。这些研究已经产生了许多有用的药物,如奎宁(来自金鸡纳属),地高辛(来自洋地黄属)以及抗癌药物紫杉醇(来自短叶红豆杉)和长春新碱和长春花碱(来自玫瑰长春花)。然而,观察到的粗提取物的生物活性往往大大增强,甚至完全不同于单个成分[32,81]。粗植物提取物可能含有数百甚至数千种不同的化学成分,它们以复杂的方式相互作用。通常情况下,人们不知道提取物是如何起作用的,即使它的治疗效果已经得到证实。因此,传统药物的植物化学和机理研究可能是复杂的,往往难以确定单一化合物/生物活性的关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Plants of the Genus Syzygium (Myrtaceae): A Review on Ethnobotany, Medicinal Properties, and Phytochemistry
Plants have been used as therapeutic agents since the start of civilization. In many developing countries, herbal medicinal systems remain important in the treatment of many ailments. Ayuvedic medicine is still commonly practiced within India with an estimated 85% of Indians still using crude plant preparations for the treatment of wide variety of diseases and ailments [79]. Traditional Chinese medicine (TCM) and African medicinal systems also account for major portion of healthcare in their populations. Even in countries where allopathic/Western medicine is dominant, medicinal plants still make significant contributions. Furthermore, many people are returning to herbal medicine systems due to the perception that natural medicines are often a safer alternative than allopathic drugs. Individuals are also seeking treatments for diseases, which have not yet been remedied by modern medicine. Many of the prescription drugs currently marketed for a wide variety of ailments were originally isolated from plants and/or are semi-synthetic analogues of phytochemicals. It has been estimated that approximately 25% of all prescription drugs currently in use are of plant origin [122, 194]. Furthermore, 75% of new anticancer drugs marketed between 1981 and 2006 were derived from plant compounds [122]. Traditional plant-based medicines are generally used as crude formulations (e.g., infusions, tinctures and extracts, essential oils, powders, poultices, and other herbal preparations). Modern natural product drug discovery generally focuses on isolating and characterizing the individual phytochemical components with the aim of producing an analogue with increased bioactivity/bioavailability. Such studies have given rise to many useful drugs such as quinine (from Cinchona spp.), digoxin (from Digitalis spp.) as well as the anticancer drug paclitaxel (from Taxus brevifolia Nutt.) and vincristine and vinblastine (from Vinca rosea). However, the bioactivities observed for crude extracts are often much enhanced or even entirely different to those seen for the individual components [32, 81]. Crude plant extracts may contain hundreds, or even thousands, of different chemical constituents that interact in complex ways. Often it is not known how an extract works, even when its therapeutic benefit is well established. Thus, phytochemical and mechanistic studies of traditional medicines may be complex, and it is often difficult to assign single compound/bioactivity relationship.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信